After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

R-Evolution Worldwide is glad to announce the launch of a collaboration with the University of Salento, (the local University, in southern Italy) and with the University of Sciences, Techniques and

Read More

Tenth EDCTP Forum October 2021: Equity in Research for Health

The Tenth biennal EDCTP Forum took place virtually, because of COVID-19 pandemic, from 17th to 21st  October 2021, hosted by the National Institute of Health (INS), Mozambique and the Health Research Centre

Read More

ITAIL-COVID-19 Project second press release

Summarising the latest most important achievements, the project ITAIL-COVID-19 (Integrated Testing Approaches and Intensive Laboratory training as strategy against COVID-19) second press release is now available: click here to download.

Read More